Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian I Rini

Showing results (91-100 of 401) with videos related to

Pageof 41
Sort By:
BJU International|April 29, 2006
Clinical trials in patients with biochemically relapsed prostate cancerAmy M Lin, Brian I Rini, Eric J Small
Clinical Genitourinary Cancer|July 25, 2006
Clinical activity of sorafenib and sunitinib in renal cell carcinoma refractory to previous vascular endothelial growth factor-targeted therapy: two case reportsPhilip E Shaheen, Brian I Rini, Ronald M Bukowski
BJU International|July 27, 2005
Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: biology, clinical results and future developmentBrian I Rini, Jeffrey A Sosman, Robert J Motzer
Advances in Experimental Medicine and Biology|August 7, 2010
Von Hippel Lindau syndromeJenny J Kim, Brian I Rini, Donna E Hansel
Nature Cancer|April 16, 2025
Biomarker-informed care for patients with renal cell carcinomaMackenzie B McKinnon, Brian I Rini, Scott M Haake
Current Opinion in Oncology|March 23, 2006
Renal cell carcinomaBrian I Rini, Steven C Campbell, W Kimryn Rathmell
Current Opinion in Oncology|April 7, 2007
Renal cell carcinomaW Kimryn Rathmell, Caroline A Martz, Brian I Rini
Clinical Genitourinary Cancer|October 10, 2006
Current data with mammalian target of rapamycin inhibitors in advanced-stage renal cell carcinomaG Kesava Reddy, Tariq I Mughal, Brian I Rini
Seminars in Oncology|October 19, 2006
The current role of angiogenesis inhibitors in the treatment of renal cell carcinomaToni K Choueiri, Ronald M Bukowski, Brian I Rini
Cancers|October 14, 2022
Emerging Targets in Clear Cell Renal Cell CarcinomaYu-Wei Chen, Brian I Rini, Kathryn E Beckermann
Pageof 41

Showing results (91-100 of 401) with videos related to

Sort By:
Pageof 41
BJU International|April 29, 2006
Clinical trials in patients with biochemically relapsed prostate cancerAmy M Lin, Brian I Rini, Eric J Small
Clinical Genitourinary Cancer|July 25, 2006
Clinical activity of sorafenib and sunitinib in renal cell carcinoma refractory to previous vascular endothelial growth factor-targeted therapy: two case reportsPhilip E Shaheen, Brian I Rini, Ronald M Bukowski
BJU International|July 27, 2005
Therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: biology, clinical results and future developmentBrian I Rini, Jeffrey A Sosman, Robert J Motzer
Advances in Experimental Medicine and Biology|August 7, 2010
Von Hippel Lindau syndromeJenny J Kim, Brian I Rini, Donna E Hansel
Nature Cancer|April 16, 2025
Biomarker-informed care for patients with renal cell carcinomaMackenzie B McKinnon, Brian I Rini, Scott M Haake
Current Opinion in Oncology|March 23, 2006
Renal cell carcinomaBrian I Rini, Steven C Campbell, W Kimryn Rathmell
Current Opinion in Oncology|April 7, 2007
Renal cell carcinomaW Kimryn Rathmell, Caroline A Martz, Brian I Rini
Clinical Genitourinary Cancer|October 10, 2006
Current data with mammalian target of rapamycin inhibitors in advanced-stage renal cell carcinomaG Kesava Reddy, Tariq I Mughal, Brian I Rini
Seminars in Oncology|October 19, 2006
The current role of angiogenesis inhibitors in the treatment of renal cell carcinomaToni K Choueiri, Ronald M Bukowski, Brian I Rini
Cancers|October 14, 2022
Emerging Targets in Clear Cell Renal Cell CarcinomaYu-Wei Chen, Brian I Rini, Kathryn E Beckermann
Pageof 41